v3.26.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating Activities    
Net income $ 439.0 $ 397.0
Adjustments to reconcile net income to net cash flows provided by (used in) operating activities:    
Depreciation, amortization and accretion 71.0 55.0
Provision for credit losses 59.5 67.1
Deferred tax expense (benefit) 5.0 17.0
Loans originated for sale (1,383.0) (1,225.0)
Loans sold 1,471.0 1,182.0
Net (gains) losses on sale of loans (24.0) (12.0)
Net change in:    
Interest receivable (9.0) (1.0)
Interest payable 5.0 (3.0)
Bank owned life insurance, excluding purchases (9.0) (7.0)
Other, net 75.0 (116.0)
Net cash flows provided by (used in) operating activities 700.0 354.0
Investing Activities    
Net change in loans and leases, excluding sales and transfers (1,784.0) (1,073.0)
Debt securities available for sale:    
Purchases (770.0) (625.0)
Maturities/payments 630.0 560.0
Debt securities held to maturity:    
Purchases (641.0) (386.0)
Maturities/payments 360.0 324.0
Increase in premises and equipment (76.0) (77.0)
Net proceeds from sales of portfolio loans 194.0 5.0
Net cash flows provided by (used in) investing activities (2,087.0) (1,272.0)
Financing Activities    
Deposits 791.0 1,333.0
Short-term borrowings 984.0 649.0
Proceeds from issuance of long-term borrowings 121.0 529.0
Repayment of long-term borrowings (220.0) (1,444.0)
Repurchases of common stock (134.0) (32.0)
Cash dividends paid on common stock (136.0) (131.0)
Other, net 9.0 8.0
Net cash flows provided by (used in) financing activities 1,415.0 912.0
Net Increase (Decrease) in Cash and Cash Equivalents 28.0 (6.0)
Cash and cash equivalents at beginning of period 2,498.0 2,419.0
Cash and Cash Equivalents at End of Period $ 2,526.0 $ 2,413.0